dc.contributor.author | Olewe , K Perez , Shehu Shagari Awandu, Munde,O Elly , Anyona,B Samuel, Raballah Evans, Asito S Amolo, Ogola Sidney, Ndenga Erick, Onyango, O Clinton , Rosemary Rochford, Douglas J Perkins, Ouma Collins | |
dc.date.accessioned | 2023-06-26T12:00:31Z | |
dc.date.available | 2023-06-26T12:00:31Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/5742 | |
dc.description | https://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11063-2 | en_US |
dc.description.abstract | Epstein Barr virus (EBV)-associated endemic Burkitt’s Lymphoma pediatric cancer is associated with
morbidity and mortality among children resident in holoendemic Plasmodium falciparum regions in western Kenya. P.
falciparum exerts strong selection pressure on sickle cell trait (SCT), alpha thalassemia (-α3.7/αα), glucose-6-phosphate
dehydrogenase (G6PD), and merozoite surface protein 2 (MSP-2) variants (FC27, 3D7) that confer reduced malarial
disease severity. The current study tested the hypothesis that SCT, (-α3.7/αα), G6PD mutation and (MSP-2) variants
(FC27, 3D7) are associated with an early age of EBV acquisition. | en_US |
dc.publisher | BioMed Central | en_US |
dc.subject | Alpha thalassemia, SCT, G6PD mutations, MSP-2, EBV | en_US |
dc.title | Hemoglobinopathies, merozoite surface protein-2 gene polymorphisms, and acquisition of Epstein Barr virus among infants in Western Kenya | en_US |
dc.type | Article | en_US |